News
Are We Ready for a Blood Test for Cancer?
What if screening for cancer was as easy as checking your cholesterol? That’s the promise of techniques currently in development that may one day make it possible to detect the earliest stages of cancer with an annual blood draw. So-called "liquid biopsies" involve extracting free-floating cancer
E-cigarettes, as Used, Aren't Helping Smokers Quit, Study Shows
Electronic cigarettes are widely promoted and used to help smokers quit traditional cigarettes, but a new analysis from UC San Francisco found that adult smokers who use e-cigarettes are actually 28 percent less likely to stop smoking cigarettes. The study — a systematic review and meta-analysis of
NCCN Awards Research Grants to Five Investigators to Study Effectiveness of Enzalutamide in Various Cancers
FORT WASHINGTON, PA — The National Comprehensive Cancer Network ® ( NCCN ® ) Oncology Research Program ( ORP ) has awarded five grants to investigators to evaluate and define the pre-clinical and clinical effectiveness of enzalutamide in mantle cell lymphoma and endometrial, hepatocellular, and
Biochemist James Wells Among 12 UC Innovators Elected to National Academy of Inventors
Thirteen University of California innovators have been elected as fellows to the prestigious National Academy of Inventors for work that is transforming semiconductor manufacturing, boosting the efficiency of biofuels and saving lives through the creation of new biomedical technologies. The newest
Researchers Create Cellular "ORACLs" to Aid Drug Discovery
A team of researchers at UC San Francisco has devised a new approach for early stage drug discovery that uses techniques from the world of computer vision in combination with a powerful new tool: a lineage of genetically modified cancer cells in a dish that change their appearance when treated with
UCSF Speakers Announced for 2016 Personalized Medicine World Conference
The lineup is finalized for the 2016 Personalized Medicine World Conference, with nine scheduled talks by UCSF leaders and faculty. The conference, co-sponsored this year by UCSF, is the premier gathering in precision medicine, attracting experts and executives in health care, biotechnology, venture
Purity' Of Tumor Samples May Significantly Bias Genomic Analyses
A new study by UC San Francisco scientists shows that the proportion of normal cells, especially immune cells, intermixed with cancerous cells in a given tissue sample may significantly skew the results of genetic analyses and other tests performed both by researchers and by physicians selecting